Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
CRMD
#2456
CorMedix Inc.
7.130
0
-1.79%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-1.79%
Monatliche Änderung
-8.24%
6 month change
-36.90%
Jahresänderung
-36.90%
Vorheriger Schlusskurs
7.260
0
Open
7.130
0
Bid
Ask
Low
7.130
0
High
7.130
0
Volumen
99
Märkte
Aktien
Gesundheitswesen
CRMD
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
38.02 M
38.73 M
44.5 M
54.98 M
65.18 M
—
Valuation ratios
Enterprise value
240.61 M
122.9 M
142.86 M
163.64 M
487.32 M
2.47 B
Price to earnings ratio
—
-0.02
-5.65
-4.14
-27
19
Price to sales ratio
—
2.27
2 573.79
—
10.97
26.44
Price to cash flow ratio
—
-0.02
-6.91
-5
-9.42
13.81
Price to book ratio
—
0.01
3.06
2.74
5.63
9.71
Enterprise value to EBITDA ratio
-8.88
-4.18
-4.68
-3.35
-22.1
24.24
Profitability ratios
Return on assets %
-0.45
-0.41
-0.48
0.56
-0.15
0.47
Return on equity %
-0.5
-0.45
-0.54
0.66
-0.21
0.72
Return on invested capital %
-12.93 K
-5 882.72
-4 602.58
-7 277.18
-457.82
812.79
Gross margin %
14.37
22
94.29
—
92.66
376.73
Operating margin %
-11.38 K
-15.42 K
-46.82 K
—
-51.43
191.37
EBITDA margin %
-11.32 K
-15.39 K
-46.69 K
—
-50.71
200.13
Net margin %
-9 207.7
-14.77 K
-45.41 K
—
-41.24
249.97
Liquidity ratios
Quick ratio
11.54
12.43
9.44
6.78
3.16
16.4
Current ratio
11.58
12.44
9.44
6.97
3.39
17.36
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0
0
0
0.43
1.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-222.02
-0.6
-0.75
-0.86
0.97
EBIT per share
—
-308.94
-0.76
-0.96
-0.38
1.42
EBITDA per share
—
-308.29
-0.76
-0.96
-0.37
1.47
Total debt per share
—
—
—
—
—
—
Cash per share
—
687.05
1.46
1.49
0.88
5.3
Net current asset value per share
—
697.57
1.48
1.56
1.95
10.51
Tangible book value per share
—
659.05
1.37
1.38
1.41
5.7
Working capital per share
—
641.48
1.32
1.34
1.37
7.44
Book value per share
—
659.05
1.37
1.38
1.44
10.51
Nachrichten
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet?
Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings?
CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock?
CorMedix Inc. (CRMD) Analyst/Investor Day Transcript
CorMedix Inc. (CRMD) Analyst/Investor Day - Slideshow (NASDAQ:CRMD) 2026-02-11
CorMedix: Citizens bekräftigt hohes Kursziel und sieht Milliardenpotenzial bei REZZAYO
CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside
CorMedix stock rises after announcing $75 million share buyback plan
CorMedix startet Aktienrückkaufprogramm über 75 Millionen US-Dollar
CorMedix announces $75 million share repurchase program
CRMD Down 31% in a Month: Is This an Indication to Sell the Stock?